The US National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), has joined as a partner for a Phase II proof-of-concept clinical trial of a...
The world’s leading pharmaceutical companies, the US, UK and UAE governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, coordinated push to...
International research that drew on New Zealand’s ground-breaking meningococcal B vaccine campaign is being hailed as a possible breakthrough in the fight against the deadly disease.
Dividing her days between treating malaria in Kenya’s coastal regions and administering the latest malaria vaccine prototype, Dr. Patricia Njuguna has high hopes for preventing a disease that annually claims more...
The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these...
Proper planning before the introduction of new vaccines into a developing country’s active immunization program could prevent storage problems and transportation bottlenecks